All good points Bripoz. I'm a bit glass half full on VLA. I think the constant manipulation downwards presents the further buying opportunities. I don't think the SP will matter at all when a licensing deal or takeover occurs, rather they will be based on the potential markets for each drug that Cavatak can cure. To me if the SP was $1.20 today it would make no difference as takeover will be more like $5.